CClinicalTrials.gg
CompletedNCT06307561Updated Mar 13, 2024

The Effect of Dystonia Severity on Participation in Daily Living Activities and Caregivers in Children of Cerebral Palsy With Secondary Dystonia

An observational study in Secondary Dystonia and Cerebral Palsy, Mixed, sponsored by Acıbadem Atunizade Hospital. Completed at 1 site in Turkey. Open to participants aged 3 Years to 15 Years. Per ClinicalTrials.gov, last updated 2024-03-13.

Sponsored by Acıbadem Atunizade Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
20
Ages
3 Years to 15 Years
Sex
All
01

Study summary

Dystonia is the most common movement disorder in the pediatric population after spasticity. It can affect normal motor development and cause significant motor retardation. The presence of dystonia may affect motor function, pain, and ease of care in CP. Additionally, it can cause serious difficulties in daily living activities and social participation and long-term joint deformity. The increase in the severity of dystonia in CP children with secondary dystonia may affect the quality of life, activity and participation of the children, as well as the caregiver. The importance of caregivers is an undeniable fact, especially in these patient groups. This study aims to investigate the burden of dystonia severity on the participation in daily living activities and caregivers of children with CP with secondary dystonia.

Read the detailed description

It's an observational study. Purpose of the study: Investigating the burden of dystonia severity on the participation in daily living activities and caregivers of children with CP with secondary dystonia.

  • Does dystonia severity affect participation in daily life activities in CP children with secondary dystonia?
  • Does the severity of dystonia in children with CP with secondary dystonia affect the burden on the caregiver?
  • Are the participation in daily living activities and caregiver burden of children with CP with secondary dystonia related to each other?

Total of 20 CP cases with secondary dystonia who applied to Acıbadem University Department of Pediatric Neurosurgery will be included in the study.

Dystonia severity of these cases will be evaluated with the Barry-Albright Dystonia Scale (BADS). Children's participation in daily living activities will be evaluated with The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD), and the burden on the caregiver will be evaluated with the Care and Comfort Hypertonicity Questionnaire (CCHQ).

02

Conditions studied

  • Secondary Dystonia
  • Cerebral Palsy, Mixed

Keywords

  • Dystonia
  • Participation
  • Caregiver
  • Burden
03

In context

Neoplasm Metastasis

3,517 studies on the registry are indexed under Neoplasm Metastasis; 884 are open to participants now.

This study's enrollment of 20 is below the median of 121 across 594 observational studies indexed under Neoplasm Metastasis.

Browse Neoplasm Metastasis studies →

Lead sponsor

Acıbadem Atunizade Hospital is the lead sponsor of 13 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Total of 20 cases CP with secondary dystonia, aged between 3-15 years were included in the study.

Inclusion criteria

  • Total of 20 cases CP with secondary dystonia, aged between 3-15 years were included in the study.
  • Obtaining voluntary consent from the family.

Exclusion criteria

Exclusion Criteria:

  • Having a surgical operation procedure on the musculoskeletal system.
  • Receiving BoNT-A in the last 6 months.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
20 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The Barry-Albright Dystonia Scale (BADS)

    The Barry-Albright Dystonia Scale designed for secondary dystonia and presence of dystonia in various body parts. It is a 5-point, criterion-based, ordinal scale designed to assess dystonia in eight body regions: eyes, mouth, neck, trunk, and the four extremities. Raters score dystonia as none (0), slight (1), mild (2), moderate (3), or severe (4).

    Time frame: baseline

  2. The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD)

    The Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) is a measure of caregivers' perceptions of activity limitations, health status, well-being, and ease of care for children with severe cerebral palsy (CP). The CPCHILD consists of 36 items comprising the following domains: (1) Personal Care; (2) Positioning, Transfer, and Mobility; (3) Communication and Social Interaction; (4) Comfort, Emotions, and Behavior; (5) Health; and (6) Overall Quality Of Life.

    Time frame: baseline

  3. The Care and Comfort Hypertonicity Questionnaire (CCHQ)

    The Care and Comfort Hypertonicity Questionnaire (CCHQ) is an interview questionnaire consisting of 27 questions divided into four scales: personal care,positioning/transferring, comfort and interaction/communication. Questions are answeredusing a 7-point Likert scale; mean scale score is calculated. The interview takes approximately10 min to administer. It provides a measure of functional limitation and has some quality-of-life elements with questions relating to pain and self-esteem. It indicates disease severity interms of degree of disability.

    Time frame: baseline

07

Study locations

1 site
  • Acıbadem Altunizade Hospital
    Istanbul, Altunizade 34662, Turkey
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made available to other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06307561
Lead sponsor
Acıbadem Atunizade Hospital
Responsible party
Gizem Gurzoglu (Pediatric Physiotherapist, Acıbadem Atunizade Hospital) — Principal investigator
First posted
Mar 13, 2024
Start date
Jan 1, 2021
Primary completion
Jan 1, 2024
Completion
Jan 1, 2024
Last update
Mar 13, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion